SCNX
Scienture Holdings, Inc.
NASDAQ: SCNX · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.39
+5.08% today
Updated 2026-04-30
Market cap
$15.56M
P/E ratio
—
P/S ratio
36.05x
EPS (TTM)
$-2.70
Dividend yield
—
52W range
$0 – $3
Volume
3.6M
Scienture Holdings, Inc. (SCNX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
1,870.00%
ROE
-55.60%
ROA
-10.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-8725.00 | — | — | — |
| 2007 | — | $-28186.00 | — | — | — |
| 2008 | — | $-28.50M | — | — | — |
| 2013 | $955881.00 | $-2.09M | 1.24% | -218.02% | -218.78% |
| 2014 | $1.50M | $-2.01M | 70.59% | -95.67% | -134.47% |
| 2015 | $2.91M | $-1.12M | 93.48% | -4.71% | -38.36% |
| 2016 | $2.48M | $-2.76M | 99.34% | -40.59% | -111.21% |
| 2017 | $2.93M | $288983.00 | 100.00% | 13.48% | 9.86% |
| 2018 | $3.83M | $9038.00 | 88.28% | -2.29% | 0.24% |
| 2019 | $7.44M | $-284428.00 | 65.50% | 1.68% | -3.82% |
| 2020 | $17.12M | $-2.54M | 33.33% | -14.64% | -14.81% |
| 2021 | $9.89M | $-5.32M | 47.99% | -53.51% | -53.75% |
| 2022 | $10.25M | $-3.47M | 53.85% | -28.45% | -33.87% |
| 2023 | $1.36M | $-17.84M | 3.60% | -322.36% | -1,308.34% |
| 2024 | $136643.00 | $9.07M | 4.39% | -10,758.70% | 6,634.66% |
| 2025 | $431609.00 | $-41.51B | -37.14% | -3,763.78% | -9,618,025.57% |